We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Cephalon, Teva Settle Patent Dispute Over Provigil

Law360 (December 11, 2005, 12:00 AM EST) -- Cephalon Inc. and Israeli generic-drug maker Teva Pharmaceutical Industries Ltd. have struck a deal to put an end to their patent disputes involving Cephalon's narcolepsy drug Provigil, the two companies said....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.